Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Comparison of model- and design-based approaches to detect the treatment effect and covariate by treatment
Burak Aydin1, James Algina2, Walter L Leite2
1School of Education, Recep Tayyip Erdogan University, Rize, Turkey. burak.aydin@erdogan.edu.tr.
Abstract:
In this study, we evaluated the estimation of three important parameters for data collected in a multisite cluster-randomized trial (MS-CRT): the treatment effect, and the treatment by covariate interactions at Levels 1 and 2. The Level 1 and Level 2 interaction parameters are the coefficients for the products of the treatment indicator, with the covariate centered on its Level 2 expected value and with the Level 2 expected value centered on its Level 3 expected value, respectively. A comparison of a model-based approach to design-based approaches was performed using simulation studies. The results showed that both approaches produced similar treatment effect estimates and interaction estimates at Level 1, as well as similar Type I error rates and statistical power. However, the estimate of the Level 2 interaction coefficient for the product of the treatment indicator and an arithmetic mean of the Level 1 covariate was severely biased in most conditions. Therefore, applied researchers should be cautious when using arithmetic means to form a treatment by covariate interaction at Level 2 in MS-CRT data.
Related Concept Videos
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Factorial Design
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Group Design

